Aharonov A, Abramsky O, Tarrab-Hazdai R, Fuchs S
Lancet. 1975 Aug 23;2(7930):340-2. doi: 10.1016/s0140-6736(75)92779-8.
Sera from patients with myasthenia gravis (M.G.) were studied by the quantitative micro-scale complement-fixation assay for the presence of humoral antibodies against acetylcholine receptor (AChR). The purified receptor was extracted from the electrogenic tissue of the electric ray, Torpedo californica. A significant difference in the antibody titres was observed between myasthenic and non-myasthenic patients. Out of fifteen patients with myasthenia gravis, at least 12 (80%) had antibodies against AChR. Only one case out of twenty-four controls had an indication of anti-receptor antibodies. In view of observations on the role of AChR as the autoantigen in myasthenia gravis, such antibodies may have significance in producing the neuro-muscular block characteristic of the disease.
采用定量微量补体结合试验,研究重症肌无力(M.G.)患者血清中是否存在抗乙酰胆碱受体(AChR)的体液抗体。纯化的受体从电鳐(Torpedo californica)的发电组织中提取。观察到重症肌无力患者和非重症肌无力患者的抗体滴度存在显著差异。在15例重症肌无力患者中,至少12例(80%)有抗AChR抗体。24例对照中只有1例有抗受体抗体的迹象。鉴于对AChR作为重症肌无力自身抗原作用的观察,此类抗体可能在产生该疾病典型的神经肌肉阻滞方面具有重要意义。